Wall Street Analyst Initiated AMGEN Inc [AMGN]. What else is Wall St. saying

AMGEN Inc [NASDAQ: AMGN] gained 0.08% or 0.22 points to close at $278.32 with a heavy trading volume of 5466094 shares.

The daily chart for AMGN points out that the company has recorded -9.45% loss over the past six months.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

If we look at the average trading volume of 2.63M shares, AMGN reached to a volume of 5466094 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here is what top equities market gurus are saying about AMGEN Inc [AMGN]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for AMGN shares is $329.57 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on AMGN stock is a recommendation set at 2.26. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Wolfe Research have made an estimate for AMGEN Inc shares, keeping their opinion on the stock as Peer Perform, with their previous recommendation back on November 15, 2024. While these analysts kept the previous recommendation, Citigroup raised their target price to Neutral. The new note on the price target was released on November 14, 2024, representing the official price target for AMGEN Inc stock. Previously, the target price had yet another raise to $380, while Bernstein analysts kept a Outperform rating on AMGN stock. On October 14, 2024, analysts increased their price target for AMGN shares from 320 to 333.

The Average True Range (ATR) for AMGEN Inc is set at 8.60, with the Price to Sales ratio for AMGN stock in the period of the last 12 months amounting to 4.63. The Price to Book ratio for the last quarter was 19.87, with the Price to Cash per share for the same quarter was set at 16.76. Price to Free Cash Flow for AMGN in the course of the last twelve months was 23.81 with Quick ratio for the last quarter at 0.96.

Trading performance analysis for AMGN stock

AMGEN Inc [AMGN] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -5.33. With this latest performance, AMGN shares dropped by -12.81% in over the last four-week period, additionally sinking by -9.45% over the last 6 months – not to mention a rise of 2.15% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for AMGN stock in for the last two-week period is set at 32.37, with the RSI for the last a single of trading hit 31.27, and the three-weeks RSI is set at 33.93 for AMGEN Inc [AMGN]. The present Moving Average for the last 50 days of trading for this stock 310.19, while it was recorded at 279.87 for the last single week of trading, and 305.66 for the last 200 days.

AMGEN Inc [AMGN]: A deeper dive into fundamental analysis

AMGEN Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.96 and a Current Ratio set at 1.32.

AMGEN Inc [AMGN]: An earnings per share (EPS) analysis

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for AMGN. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for AMGEN Inc go to 5.00%.

An analysis of Institutional ownership at AMGEN Inc [AMGN]

There are presently around $81.05%, or 81.25%% of AMGN stock, in the hands of institutional investors. The top three institutional holders of AMGN stocks are: VANGUARD GROUP INC with ownership of 51.87 million shares, which is approximately 9.6779%. BLACKROCK INC., holding 46.04 million shares of the stock with an approximate value of $$14.39 billion in AMGN stocks shares; and BLACKROCK INC., currently with $$9.05 billion in AMGN stock with ownership which is approximately 5.4051%.